4 unknown, 2 recruiting, 2 withdrawn, 1 active not recruiting. 3 Phase 3, 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
Follow Ulcerative Colitis Chronic: new trials by email Literature Review of Ulcerative Colitis Chronic trials Research Report on Ulcerative Colitis Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis Eltrekibart, Mirikizumab, Placebo - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 2 | Active not recruiting | Eli Lilly and Company | 143 | 2024-10-10 | 2026-10-07 |
| A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Completed | Eli Lilly and Company | 172 | 2023-05-17 | 2026-06-10 |
| R-3750 in Patients With Mild to Moderate Ulcerative Colitis R-3750 - Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | Phase 1 | Recruiting | Rise Therapeutics LLC | 36 | 2023-02-27 | 2026-06-12 |
| Prevalence of Encephalopathy in Patients With Inflammatory Bowel Diseases Inflammatory Bowel Diseases, Ulcerative Colitis Chronic | Unknown | Centre of Postgraduate Medical Education | 80 | 2022-10-01 | 2023-04-27 | |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
| Stem Cells for the Treatment of Pouchitis Mesenchymal Stem Cells (MSCs) - Pouchitis, Crohn's Disease | Phase 1 | Withdrawn | The Cleveland Clinic | 2022-04-01 | 2026-04-16 | |
| Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan No intervention - Ulcerative Colitis Chronic, Crohn Disease Colon | Unknown | Kazakhstan Scientific Society for Study of intestine diseases | 2000 | 2021-12-10 | 2022-01-12 | |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Recruiting | Eli Lilly and Company | 150 | 2021-05-26 | 2026-10-07 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis No intervention - Ulcerative Colitis, Ulcerative Colitis Chronic | Withdrawn | ProgenaBiome | 2020-03-02 | 2025-06-05 | ||
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease There is no intervention in this study - Gut Microbiome, Gastrointestinal Microbiome | Suspended | ProgenaBiome | 1000 | 2019-07-11 | 2026-09-21 | |
| Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis ICG-NIRF Imaging plus ingress and egress analysis - Ulcerative Colitis, Colorectal Cancer | Not applicable | Unknown | Charite University, Berlin, Germany | 50 | 2019-02-01 | 2021-01-15 |
Colitis, Ulcerative (9) · Crohn Disease (6) · Inflammatory Bowel Diseases (4) · Colitis (2) · Colorectal Neoplasms (2) · Irritable Bowel Syndrome (2) · Pouchitis (2) · Acne Vulgaris (1) · Adenomatous Polyposis Coli (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Anastomotic Leak (1) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Autism Spectrum Disorder (1)
Gastroenteritis (11) · Digestive System Diseases (10) · Gastrointestinal Diseases (10) · Intestinal Diseases (10) · Colonic Diseases (9) · Colitis (7) · Inflammatory Bowel Diseases (7) · Adenoma (2) · Central Nervous System Diseases (2) · Colonic Diseases, Functional (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Neoplasms (2) · Enteritis (2) · Gastrointestinal Neoplasms (2) · Genetic Diseases, Inborn (2)
mirikizumab (3) · Prednisolone (1)
Eli Lilly and Company (3) · ProgenaBiome (2) · Assiut University (1) · Centre of Postgraduate Medical Education (1) · Charite University, Berlin, Germany (1) · Kazakhstan Scientific Society for Study of intestine diseases (1) · Rise Therapeutics LLC (1) · The Cleveland Clinic (1)
United States (7) · Germany (4) · Poland (4) · Belgium (3) · Italy (3) · Canada (2) · Czechia (2) · France (2) · Hungary (2) · Japan (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Austria (1) · Brazil (1)
Sabine Hazan, MD (2) · Amy L Lightner, MD (1) · Anna Pietrzak, MD (1) · Jamilya Kaibullayeva, PhD (1)